Figure 8.
Depletion of serum l-arginine is associated with elevated serum and liver arginase activity during periods of HBV disease activity in patients with CHB. (a) Serum l-arginine levels were compared in healthy donors (n = 21), patients with low-to-moderate liver inflammation (ALT < 100 IU/liter; n = 13), and patients with high liver inflammation (ALT > 100 IU/liter; n = 11; control vs. high ALT P < 0.01; low ALT vs. high ALT P < 0.05). (b) Graphs depict longitudinal fluctuations in serum arginase activity (dashed line, IU/liter) in association with viral load (solid gray line, HBV DNA, IU/ml) and ALT (shaded histogram, IU/liter) for two patients with flares of CHB. (c) The arginase activity of liver homogenates is shown for five individuals with CHB and five individuals with nonviral liver pathology.